Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Bicycle Therapeutics Plc ADR

(NASDAQ: BCYC)
Add to Portfolio
-0.48 (-5.27%)
as of Nov 21, 2019

Profile
Ticker Symbol BCYC
Exchange NASDAQ
Contact Information
B900 BABRAHAM RESEARCH CAMPUS
CAMBRIDGE, X0 GBR
P: 44-12-2326-1503
CEO/President Kevin Lee
Earnings at a Glance
Earnings 09/30/19
-0.53
06/30/19
-1.40
03/31/19
-7.80
12/31/18
-
Price Earnings Ratio N/A
EPS Growth N/A
Most Recent Earnings ($) -0.53
Annual EPS ($) N/A
Business Summary
Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge United Kingdom.
Industry/Sector Information not available.